Overview
With her dedication and client-focused approach, attorney Lauren Petrin* helps advise health care and life sciences companies on matters ranging from food and drug law and controlled substance regulations to government investigations and managed care.
Whether it’s the details of a viable health care payment system or a new medical product moving through the approval process, she brings her analytical skills to bear on clients’ day-to-day needs.
During law school, Lauren interned at the Food and Drug Administration in the Office of Legislation, communicating on behalf of the agency with congressional members and analyzing pending legislation. Prior to that, she served in the General Counsel’s Office of a regional hospital system, where she worked on projects with the Risk Management Director and Chief Compliance Officer, and as a paralegal an international law firm in their International Trade division.
*Admitted to the Bar under D.C. App. R. 46-A (Emergency Examination Waiver) and supervised accordingly.
Focus Areas
Services
Experience
Credentials
Education
- University of Maryland Francis King Carey School of Law (J.D., 2020)
- Health Law Certificate
- Member, Journal of Health Care Law and Policy
- President, Student Health Law Organization
- Member, Women’s Bar Association
- Boston University (B.S., cum laude, 2016)
Bar Admissions
- District of Columbia
Professional & Community Involvement
- Food and Drug Law Institute
Media
Insights
Insights
- BlogsFDA Issues Final Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors4 minute read
- PublicationsVague FDA Guidance Fails to Provide a Roadmap to Dietary Supplement Misbranding Minefield4 minute read
- PublicationsDietary Supplement Makers Face "Misbranding" Minefield, Need FDA Guidance7 minute read
- PublicationsFDA Issues Draft Recommendations for Implementing Decentralized Clinical Trials20 minute read
- BlogsFDA Issues Draft Guidance on Labeling of Plant-Based Milk Alternatives8 minute read
- BlogsStates and Feds Signal Big Changes to Telehealth Prescribing13 minute read
- BlogsFDA Issues Final and Draft Guidance Documents Regarding Food Allergen Labeling7 minute read
- BlogsAnti-Abortion Advocacy Groups’ Challenge to FDA-Approved Abortion Pill May Have Far-Reaching Consequences7 minute read
- BlogsRecent FDA Enforcement Action Colors Regulatory Landscape for Delta-8 THC Products5 minute read
- Firm AnnouncementsEpstein Becker Green Reports Telemental Health’s Influence Grows Throughout COVID-19 Pandemic6 minute read
- BlogsNavigating New Jersey’s Telemedicine Business Registry3 minute read
- BlogsDOJ’s Recent Telehealth Enforcement Action Highlights Increased Abuse of COVID-19 Waivers5 minute read
- BlogsOIG Audits on Medicare Advantage Plans Continue3 minute read
- BlogsU.S. Department of Justice Reports on Heightened Enforcement Activities Against COVID-19 Related Fraud6 minute read
- BlogsFirst Reported FCA CARES Act Settlement Announced4 minute read